Wheeler Bio brings 1 presentation to BPI 2026 in Boston, and exhibits. Its session covers AI-enabled clone selection that weighs many variables at once to improve cell line development. Wheeler Bio is an antibody-focused CDMO that runs from cell line development through early clinical GMP supply.
| Organization | BPI 2026 Attendance |
|---|---|
Wheeler Bio Oklahoma City, Oklahoma | 1 Chief Development Officer |
Antibody-focused contract development and manufacturing organization offering cell line development through early clinical GMP supply. | Booth Exhibiting (no floor booth listed) Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm Talk Wed Sep 23 3:00pm–3:30pm |
Instantly find 20 buyers from Wheeler Bio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction